REQUEST A DEMO
Total
USD $0.00
Search more companies

Exir Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Exir Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Exir Pharmaceutical Company is an Iranian drug manufacturer and importer set up in 1984 in Tehran. Its factory was built in the province of Lorestan. It is equipped with advanced production lines and laboratory. The company currently produces 160 pharmaceuticals in various finished dosage forms, including tablets, capsules, ampoules, syrups and injectable vials. Besides the medicines, the company produces food supplements and medical devices. It exports its products to 13 countries, including Ukraine, Azerbaijan, Tajikistan, the Philippines, Lebanon and Armenia.

Legal Address
18 Km Of Tehran-Karaj Special Road, Darupakhsh Street, Farvardin St. 3 - Door No. 5 Darupakhsh
Tehran; Tehran; Postal Code: 1397116396

Contact Details: Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.exir.co.ir

Basic Information
Total Employees:
Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1985
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
53.71%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Exir Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
66.6%
Total operating revenue
66.52%
Operating profit (EBIT)
78.8%
EBITDA
77.79%
Net Profit (Loss) for the Period
67.86%
Total assets
60.63%
Total equity
44.7%
Operating Profit Margin (ROS)
3.07%
Net Profit Margin
0.22%
Return on Equity (ROE)
10.12%
Debt to Equity Ratio
33.09%
Quick Ratio
0.02%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?